share_log

HC Wainwright & Co. Reiterates Buy on Lyell Immunopharma, Maintains $9 Price Target

HC Wainwright & Co. Reiterates Buy on Lyell Immunopharma, Maintains $9 Price Target

HC Wainwright & Co.重申买入 Lyell Immunopharma,维持9美元的目标价
Benzinga ·  2023/05/05 06:54

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Lyell Immunopharma (NASDAQ:LYEL) with a Buy and maintains $9 price target.

HC Wainwright & Co. 分析师米切尔·卡普尔重申了Lyell Immunopharma(纳斯达克股票代码:LYEL)的买入并维持9美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发